Additional file 4 of Pexidartinib treatment in Alexander disease model mice reduces macrophage numbers and increases glial fibrillary acidic protein levels, yet has minimal impact on other disease phenotypes
posted on 2021-03-09, 04:41authored byMichelle M. Boyd, Suzanne J. Litscher, Laura L. Seitz, Albee Messing, Tracy L. Hagemann, Lara S. Collier
Additional file 4: Additional Figure 4: Pexidartinib treatment does not impact expression of Plp1 and Mog. Legend: RT-qPCR for Plp1 for the olfactory bulb (a) and hippocampus (b), Mog for the olfactory bulb (c) and hippocampus (d). Statistical analyses: One-way ANOVA with Bonferroni’s post-test for the indicated comparisons, n.s. = non-significant (p>0.05). N = 5-6 per group.
Funding
National Institutes of Health Institute for Clinical and Translational Research, University of Wisconsin, Madison Eunice Kennedy Shriver National Institute of Child Health and Human Development